Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
I lang tid har porteføljemanager Dan Wejse og hans partner i investeringsforeningen MW Compounders, Johannes Møller, skulle høre på, hvorfor der ikke lå nogen Novo Nordisk-aktier i deres portefølje.
Aktien var blevet solgt ved udgangen af 2022, fordi investeringen var blevet for svær at regne hjem. Siden sommeren 2024 er Novo Nordisk faldet markant, og spørgsmålet er nu, om MW Compounders igen kan regne investeringen hjem.
”Vi overvejer situationen med Novo Nordisk. Vi solgte den på lavere niveauer, og siden da er omsætningen gået meget bedre end, hvad jeg – og jeg tror de fleste andre – havde regnet med,” siger Dan Wejse.
Hør også, hvorfor han har solgt sin position i Alphabet, en aktie, som Nina Movin, adm. direktør i Otto Mønsteds Fond, netop holder fast.
Investorerne taler også om aktier som Nike og Puma samt om der er udsigt til et større inflow af investeringskroner i våbenaktier, fordi flere institutionelle investorer begynder at lempe deres investeringspolitikker.
Vært: Gro Høyer Thielst
Producer: Arjuna Alexander Kolkur Sørensen
Følg All Star porteføljen her: https://www.home.saxo/da-dk/campaigns/all-star-portfolio
Create your
podcast in
minutes
It is Free